Tango Therapeutics
TNGX
TNGX
169 hedge funds and large institutions have $1.53B invested in Tango Therapeutics in 2025 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 76 increasing their positions, 26 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
20% more funds holding
Funds holding: 141 → 169 (+28)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
2.21% more ownership
Funds ownership: 125.8% → 128.01% (+2.2%)
Holders
169
Holding in Top 10
8
Calls
$841K
Puts
$266K
Top Buyers
| 1 | +$69.8M | |
| 2 | +$36.4M | |
| 3 | +$34.8M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$33.8M |
| 5 |
CP
Caligan Partners
New York
|
+$32.1M |
Top Sellers
| 1 | -$89.3M | |
| 2 | -$51.6M | |
| 3 | -$40.8M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$26.5M |
| 5 |
PBA
Paradigm Biocapital Advisors
New York
|
-$25.9M |
